Robotic technology quantifies novel perceptual-motor impairments in patients with chronic kidney disease.

Journal: Journal of nephrology
PMID: 33400140

Abstract

BACKGROUND: Neurocognitive impairment is commonly reported in patients with chronic kidney disease (CKD). The precise nature of this impairment is unclear, due to the lack of objective and quantitative assessment tools used. The feasibility of using robotic technology to precisely quantify neurocognitive impairment in patients with CKD is unknown.

Authors

  • Jessica Anne Vanderlinden
    Centre for Neuroscience Studies, Queen's University, Kingston, ON, Canada.
  • Rachel Mary Holden
    Division of Nephrology, Department of Medicine, Queen's University, Kingston, ON, Canada.
  • Stephen Harold Scott
    Centre for Neuroscience Studies, Queen's University, Kingston, ON, Canada.
  • John Gordon Boyd
    Centre for Neuroscience Studies, Queen's University, Kingston, ON, Canada. gordon.boyd@kingstonhsc.ca.

Keywords

External Resources

Popular Topics
Recent Journals